Envista Holdings Corporation
NVST Healthcare Medical Instruments & Supplies
Envista Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.7 billion, up 8.32% from fiscal 2024.
- Revenue
- +3.22%
- EPS
- +1,855.6%
- Free cash flow
- −6.48%
- Total debt
- −1.13%
Quarter to September 2026, against a year earlier
Follow NVST
Alert me
Envista Holdings Corporation (NVST) P/S ratio
As of 5 November 2026, Envista Holdings Corporation (NVST) trades at a P/S ratio of 1.4×. Over the past ten years it has ranged from 0.0× (September 2019) to 3.7× (May 2021); the current reading is higher than 31% of that period. That is below the Medical Instruments & Supplies industry median of 2.5× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 1.3× | 1.37% |
| FY2024 | 1.3× | (15.58%) |
| FY2023 | 1.6× | (27.22%) |
| FY2022 | 2.2× | (25.63%) |
| FY2021 | 2.9× | 3.75% |
| FY2020 | 2.8× | 57.94% |
| FY2019 | 1.8× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 1.3× | (12.20%) |
| Jun 2026 | 1.5× | 0.86% |
| Mar 2026 | 1.5× | 10.41% |
| Dec 2025 | 1.3× | 3.93% |
| 28 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| NVST Envista Holdings Corporation | 1.4× |
| MMED MiniMed Group, Inc. compare | 1.7× |
| ICUI ICU Medical, Inc. compare | 1.9× |
| STVN Stevanato Group S.p.A. compare | 2.5× |
| TFX Teleflex Incorporated compare | 2.9× |
| MMSI Merit Medical Systems, Inc. compare | 3.3× |
| WRBY Warby Parker Inc. compare | 3.5× |
| ATRC AtriCure, Inc. compare | 5.0× |
| PLSE Pulse Biosciences, Inc compare | 2,559× |
| Medical Instruments & Supplies industry median | 2.5× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on NVST
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement